Skip to main content
. 2020 Sep 14;6(9):e04930. doi: 10.1016/j.heliyon.2020.e04930

Table 3.

Inhibitory effect of synthesized trans-tephrostachin 4a and derivatives 4b – 4e.

Compound Vmax Km (μM) Ki (μM) Inhibition type
Without Inhibitor 0.34 ± 0.01 173.5 ± 17.8 _____ _____
4a 0.13 ± 0.08 234.3.0 ± 35.0 29.3 ± 7.2 Mixed inhibition
4b 0.34 ± 0.01 240 ± 23.6 206.3 ± 12 Competitive inhibition
4c 0.14 ± 0.1 205.5 ± 34.7 46.42 ± 9.5 Mixed inhibition
4d 0.15 ± 0.01 247.6 ± 36.7 8.3 ± 1.7 Mixed inhibition
4e 0.36 ± 0.2 265.2 ± 37.18 197.62 ± 10.1 Competitive inhibition